Research Done Right for Your Infectious Disease Trial
AMR Clinical conducts the highest quality clinical research to improve our understanding and management of infectious diseases. This research ranges from first-in-human translational studies through to Phase IV infectious disease trials and covers diagnosis, prevention, and treatment:
- 1,000+ infectious disease trials
- 55,000+ participants enrolled
- 50+ biopharma and government agency clients
- 110% average enrollment goals achieved
- 96% average retention rate
Participant Populations
- Geriatrics
- Healthy normal volunteers
- Immunocompromised
- Maternal
- Adolescents
- Pediatrics (Newborns-Adolescents)
Clinical Research Sites for All Study Types
- Phase I, II, III, and IV
- Government-funded studies
- Combination therapies
- First-in-human studies
Research Done Right — Infectious Disease Indications
- AIDS/HIV infections
- Acellular pertussis
- Bacterial infections
- Bone & joint infections
- Chronic bronchitis
- Clostridium difficile (C. diff)
- Common cold
- Fungal infections
- Genital/perianal warts
- Hepatitis
- Hepatitis B
- Hepatitis C
- Herpes genitalis (genital herpes)
- Herpes labialis (cold sores)
- Herpes zoster (shingles)
- Influenza treatment
- Malaria/tropical infections
- Otitis media
- Picornavirus
- Pneumonia treatment
- Pneumonia
- Sepsis
- Sexually transmitted infections (STIs)
- Sinusitis
- Skin/soft tissue infections (complicated, uncomplicated)
- Streptococcal pharyngitis
- Urinary tract infection (UTI)
Recent Infectious Disease Approvals
| Sponsor | Asset | Indication | Population |
|---|---|---|---|
| AstraZeneca/Sanofi | Beyfortus | RSV vaccine | Infants |
| AstraZeneca | Flumist | Influenza A and B viruses | Adult/Pediatrics |
| AstraZeneca | Vaxzevria | SARS-CoV-2 | Adults |
| bioCSL | Optaflu | Influenza vaccine | Adults |
| GSK | Arexzvy | RSV vaccine | Adults |
| GSK | Fluarix | Influenza A and B viruses | Adult/Pediatrics |
| GSK | Penmenvy | Pentavalent meningococcal vaccine | Adult/Adolescents |
| Merck/Sanofi | Vaxelis | Hexavalent DTaP, IPV, Hib, HepB | Pediatrics |
| Moderna | Spikevax | COVID-19 mRNA vaccine | Adult/Adolescent |
| ModernaTX | mResvia | RSV vaccine | Older Adults |
| NIH/NIAID | Visby Lancet diagnostic | Detection of STIs | Adult/Adolescent |
| Novavax | Nuvaxovid | COVID-19 vaccine | Adult/Adolescent |
| OraSure Technologies | OraSure Device for HIV | HIV-1 antibody testing | Adult/Adolescent |
| Pfizer | Abrysvo | RSV vaccine | Adults |
| Pfizer | Comirnaty | COVID-19 mRNA vaccine | Adult/Adolescent |
| Pfizer | Paxlovid | Mild-moderate COVID-19 | Adult/Pediatrics |
| Pfizer | Penbraya | Pentavalent meningococcal vaccine | Pediatrics/Adolescents |
| Pfizer | Prevnar20 | 20 valent pneumococcal vaccine | Pediatric |
| Sanofi | Flublok | Influenza A and B viruses | Adults |
| Sanofi | Flulaval | Influenza A and B viruses | Adult/Pediatric |
| Sanofi | Fluzone High-Dose | Influenza A and B viruses | Older Adults |
| Sanofi | MenQuadfi | Meningococcal vaccine | Pediatrics |
